(Q43263268)

English

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence

scientific article published in November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Richard A. Larson

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Koen van Besien

object named as

Koen van Besien

1

0 references

author name string

Alexander Dew

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Shang Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Loren Joseph

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lucy A Godley

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Toyosi Odenike

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Elizabeth Rich

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Wendy Stock

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Amittha Wickrema

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andrew S Artz

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1809-1817

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Choice and interpretation of statistical tests used when competing risks are present

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Identifiers

10.3109/10428190903200790

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43263268&oldid=1985086164"